Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States
article
OA: closed
CC0
⤵ 38 in-corpus citations
AI-generated summary
This study quantified the incremental direct and indirect costs associated with endometriosis surgeries in the United States.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo compare direct and indirect costs between endometriosis patients who underwent endometriosis-related surgery (surgery cohort) and those who have not received surgery (no-surgery cohort).DesignRetrospective cohort study.SettingNot applicable.Patient(s)Endometriosis patients (aged 18-49 years) with (n = 124,530) or without (n = 37,106) a claim for endometriosis-related surgery were identified from the Truven Health MarketScan Commercial and Health and Productivity Management databases for 2006-2014.Intervention(s)Not applicable.Main outcome measure(s)Primary outcomes were healthcare utilization during 12-month pre- and post-index periods, annual direct (healthcare) and indirect (absenteeism and short- and long-term disability) costs during the 12-month post-index period (in 2014 US dollars). Indirect costs were assessed for patients with available productivity data.Result(s)Patients in the surgery cohort had significantly higher healthcare resource utilization during the post-index period and had mean annual total adjusted post-index direct costs approximately three times the costs among patients in the no-surgery cohort ($19,203 [SD $7,133] vs. $6,365 [SD $2,364]; average incremental annual direct cost = $12,838). The mean cost of surgery ($7,268 [SD $7,975]) was the single largest contributor to incremental annual direct cost. Mean estimated annual total indirect costs were $8,843 (surgery cohort) vs. $5,603 (no-surgery cohort); average incremental annual indirect cost = $3,240.Conclusion(s)Endometriosis patients who underwent surgery, compared with endometriosis patients who did not, incurred significantly higher direct costs due to healthcare utilization and indirect costs due to absenteeism or short-term disability. Regardless of the surgery type, the cost of index surgery contributed substantially to the total healthcare expenditure.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (32)
- ACOG Updates Guideline on Diagnosis and Treatment of Endometriosis via openalex
- Actuarial Analysis of Private Payer Administrative Claims Data for Women With Endometriosis via openalex
- An update on the pharmacological management of endometriosis via openalex
- Economic burden of endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: cost estimates and methodological perspective via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Evidence based surgical management of endometriosis via openalex
- Female Perspectives on Endometriosis: Findings from the Uterine Bleeding and Pain Women'S Research Study via openalex
- Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Impact of endometriosis on women's health: comparative historical data show that the earlier the onset, the more severe the disease via openalex
- Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women via openalex
- Surgical procedures and their cost estimates among women with newly diagnosed endometriosis: a US database study via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The direct and indirect costs associated with endometriosis: a systematic literature review via openalex
- W2041469258 via openalex
- W2349906771 via openalex
- W2006883643 via openalex
- W3123574146 via openalex
- W1991205857 via openalex
- W4285719527 via openalex
- W6669579114 via openalex
- W6730167542 via openalex
- W6740200389 via openalex
- W2083701448 via openalex
- W2086743128 via openalex
- W2088036598 via openalex
- W2090910599 via openalex
- W2062187131 via openalex
- W2129168200 via openalex
- W2055465597 via openalex
Cited by (38)
- How are workplace policies, organizational dysfunction, and lack of accommodations for employees with endometriosis associated with fertility-related needs, absenteeism, and productivity in the workforce? A scoping review 2026
- Cannabidiol-Enriched Extract Oil for Postoperative Management of Chronic Pelvic Pain Secondary to Endometriosis: A Randomized Clinical Trial-DREAMLAND Study 2026
- The Diagnostic Performance of Transvaginal Ultrasound for Posterior Compartment Endometriosis Compared to Laparoscopic and Histopathological Findings: A Systematic Review 2025
- Girth and transverse body dimensions in Ukrainian young women with genital endometriosis without and taking into account somatotype 2025
- Virtual Mindfulness-Based Therapy for the Management of Endometriosis Chronic Pelvic Pain: A Novel Delivery Platform to Increase Access to Care 2024
- Emergency department attendances for persistent pelvic pain are not reduced following laparoscopic surgery for women with or without endometriosis 2024
- Enhancing endometriosis care with telehealth: Opportunities and challenges 2024
- Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3) 2024
- Nutrition in the prevention and treatment of endometriosis: A review 2023
- Current treatments for endometriosis in South Korea: an analysis of nationwide data from 2010 to 2019 2023
- Mobile applications for endometriosis management functionalities: Analysis and potential 2023
- Prevalence and Annual Health Insurance Cost of Endometriosis in Hungary-A Nationwide Study Based on Routinely Collected, Real-World Health Insurance Claims Data 2023
- Comparative Study of Serum miRNA as A Biomarker for Non-Invasive Diagnosis in Suspected Versus Proven Cases of Endometriosis 2023
- Cost Estimates Associated with Diagnosis and Treatment of Endometriosis 2022
- Impact of endometriosis on women’s life decisions and goal attainment: a cross-sectional survey of members of an online patient community 2022
- Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea 2021
- Chronic opioid use and complication risks in women with endometriosis: A cohort study in <scp>US</scp> administrative claims 2021
- Eutopic endometrium from women with endometriosis and chlamydial endometritis share immunological cell types and DNA repair imbalance: A transcriptome meta-analytical perspective 2021
- Accurate diagnosis of endometriosis using serum microRNAs 2020
- What the Transcriptome of the Eutopic Endometrium from Women with Endometriosis tells us about the Disease Pathophysiology: A Brief Reflection 2020
- Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial 2020
- Transcriptome meta-analysis reveals differences of immune profile between eutopic endometrium from stage I-II and III-IV endometriosis independently of hormonal milieu 2020
- Is Endometriosis More Common and More Severe Than It Was 30 Years Ago? 2019
- Health Care Utilization and Costs Associated with Endometriosis Among Women with Medicaid Insurance 2019
- Clinical Evaluation of the Oral Gonadotropin-Releasing Hormone-Antagonist Elagolix for the Management of Endometriosis-Associated Pain 2019
- Cost–effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA 2019
- The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey 2019
- National trends in inpatient endometriosis admissions: Patients, procedures and outcomes, 2006−2015 2019
- Clinical diagnosis of endometriosis: a call to action 2019
- Hospital-Associated Cost of Endometriosis in Canada: A Population-Based Study 2019
- Patient Preferences for Endometriosis Pain Treatments in the United States 2019
- Clinical diagnosis of endometriosis: a call to action 2019
- Preliminary insights on the relation between endometriosis, pelvic pain, and employment 2018
- Development of the Painful Periods Screening Tool for endometriosis 2018
- Psychosocial impact of endometriosis: From co-morbidity to intervention 2018
- Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States 2018
- Changes in Healthcare Spending After Diagnosis of Comorbidities Among Endometriosis Patients: A Difference-in-Differences Analysis 2017
- Endometrial surgery increases direct and indirect costs 2017
Source provenance
- europepmc
- last seen: 2026-10-06T06:14:42.462031+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:25.745717+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK